This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages without signing in

Statin treatment and cataract

Authoring team

A prospective open cohort study has examined and quantified the unintended risks and benefits of statins in a large representative primary care population over a six year period.

With respect to risk of cataracts associated with statin treatment the results revealed:

  • statin use was associated with an increased risk of cataract in both men and women, apart from fluvastatin in men, owing to small numbers in the analysis
  • no significant difference between the effects of individual statins in men (P=0.32) or in women (P=0.82)
  • no evidence of a dose-response relation
  • risk was significantly increased within a year of starting statins, persisted during treatment, and returned to normal within the first year after stopping treatment
  • number needed to harm (NNH) for cataract was 33 (28 to 38)

Reference:

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.